Description

Riboxin-Darnitsa (Inosine) Ampoules 20 mg/ml 10 ml. №10

Ingredients:

• Each ampoule contains: inosine 20 mg/ml.

Dosage:

• The usual dose is 1-2 ampoules per day, administered intravenously or intramuscularly.

Indications:

• Riboxin-Darnitsa is indicated for improving myocardial metabolism, treating coronary heart disease, and supporting liver function.

Contraindications:

• Do not use Riboxin-Darnitsa if you have hypersensitivity to inosine, acute gout, or hyperuricemia.

Directions:

• Administer as directed by a healthcare professional. The solution should be clear and free from particles before use.

Scientific Evidence:

• Studies have shown that inosine, the active ingredient in Riboxin-Darnitsa, plays a crucial role in cellular energy metabolism. It improves ATP production in cardiac cells, enhancing myocardial function and cardiovascular health.
• Clinical trials suggest inosine supplementation may protect the liver by promoting hepatocyte regeneration and improving liver function markers in liver disease patients.

Additional Information:

• Riboxin-Darnitsa should be used under medical supervision, especially in patients with pre-existing conditions or taking other medications.
• Consult a healthcare provider before starting any new treatment regimen.

Riboxin-Darnitsa offers a promising therapeutic option for conditions related to impaired energy metabolism and organ dysfunction. Its mechanism of action and clinical benefits make it valuable in cardiology and hepatology treatment.